A highly selective and specific PET tracer for imaging of tau pathologies.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTInsight into the Molecular Imaging of Alzheimer's DiseaseCharacteristics of Tau and Its Ligands in PET ImagingImaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingNeuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTEAcute and chronic traumatic encephalopathies: pathogenesis and biomarkers.Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasBiomarkers in dementia: clinical utility and new directionsDevelopment of positron emission tomography β-amyloid plaque imaging agentsSpreading of pathology in neurodegenerative diseases: a focus on human studiesHigh affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionThe neuropathology of sportNeuroimaging in repetitive brain trauma.A review of neuroimaging findings in repetitive brain trauma.Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.Antibody-derived in vivo imaging of tau pathology.Tau PET imaging: present and future directions.The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using (18)F-AV45: Is Amyloid the Principal Actor in the Disease?The evolution of preclinical Alzheimer's disease: implications for prevention trials.Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model.PET Radioligands for Imaging of Tau Pathology: Current Status.Tau imaging in neurodegenerative diseases.Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controlsPharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects.Tau immunotherapy and imaging.Harnessing the immune system for treatment and detection of tau pathology.Tau Positron Emission Tomography Imaging.Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.The Prion-Like Behavior of Assembled Tau in Transgenic Mice.Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807Synthesis of Thiophene-Based Optical Ligands That Selectively Detect Tau Pathology in Alzheimer's Disease.Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies.In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line.Preclinical Evaluation of (18)F-RO6958948, (11)C-RO6931643 and (11)C-RO6924963 as Novel Radiotracers for Imaging Aggregated Tau in AD with Positron Emission Tomography.
P2860
Q26749755-161B9469-CAE0-4D31-80F7-C6F986D2958CQ26765945-D2C564F0-B4E6-4124-9CF2-7B498FEDD2F2Q26769952-81DE903A-50A3-404B-BC29-2CF6678F6876Q26770766-1686740A-AB0F-4FC0-9A3E-D3CB60F2EDFCQ26781672-4DD8CDA3-AA74-4706-9D46-32961193F6BAQ26995259-3E8DFEF3-5B1C-4362-8FF5-1487FCE7F54AQ27003078-5F9CAE78-7C42-4FED-989D-A51A8F6DB028Q27007086-E24634EF-8CD4-4321-8462-D461836DBD26Q27012742-6B3CAE95-FCB0-448D-BDF1-8E07223A9015Q28082279-AB533FAC-BD5A-45D9-A612-9631C59EBFB8Q28241366-AF3B16F1-8805-4510-92BA-634B9D50E1D2Q28383563-2C0333AB-2B5A-40C2-9359-1CAEA455C17CQ30836857-461F4904-A84A-408C-B9D8-3ECA5BDEC02FQ30938680-F43C1320-8AEC-4BFE-81E0-CF0B27AEE79FQ33795224-EA608330-7124-4313-BC72-CDEE8BCBD963Q34378321-33B2A090-EFE9-4038-B22E-E48AF116D73BQ34423050-C56E48BC-2B6F-4D50-80F1-537971345EC9Q34664345-E53C44E5-133E-418E-8F4E-C4BB34636ADEQ34680852-4F04EA00-70E7-49D2-B203-4B57799DADD2Q34687210-1F8C9760-8E50-4ED7-B4D0-AE289B9B0087Q34849048-61A923C9-625C-441A-B313-4996F4EB30ABQ36209842-16938641-B75B-4A37-B468-D8D2BCCAC859Q36241261-24921D13-FBB2-4345-A36C-82AD26B812A2Q36834567-3FC2AD8A-F462-474F-9B80-8AC0FA9AC82AQ36987267-922061E3-DF91-4CD0-8235-AF16D8EBEBE4Q37259426-503ACA46-F1BA-4D88-97B2-FBA35BBD1379Q37677783-9EC1B1D4-59FA-46EB-8138-0B16ECE981A9Q38136880-3B3F8842-9C08-4DEF-8DE2-219B2D0CBB9BQ38194049-1E8D638D-42FF-4C20-8B84-40DFEA2976C1Q39035462-D837709C-3DB3-4E9A-A033-8E9CBDDE36BBQ39035486-4C8DEF1C-FBCC-423E-9F10-C80059FE8AC3Q39035488-F96E4443-C062-4435-838D-92D16B393CFBQ41535994-E3BB61F3-EA46-48CF-9D12-FE999BF6EDBBQ41587883-608770CE-D4FE-423B-9D86-DBA7C418E67CQ42253028-7400C257-E3AB-44F5-9EF6-70E7FF4CC12FQ46304556-C4057837-D29B-4AB6-A1B6-91367E81224FQ47140361-A3BA8FF1-60F4-4B83-9E8B-DFF3C0C8793AQ47824973-3594781B-2D3E-41E7-8D45-F94C9812B788Q47835964-0345F46E-6D89-4846-8009-29D17D8F801DQ47918679-4D157BEF-CAB7-46C1-AC17-26CA528B6F20
P2860
A highly selective and specific PET tracer for imaging of tau pathologies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A highly selective and specific PET tracer for imaging of tau pathologies.
@ast
A highly selective and specific PET tracer for imaging of tau pathologies.
@en
A highly selective and specific PET tracer for imaging of tau pathologies.
@nl
type
label
A highly selective and specific PET tracer for imaging of tau pathologies.
@ast
A highly selective and specific PET tracer for imaging of tau pathologies.
@en
A highly selective and specific PET tracer for imaging of tau pathologies.
@nl
prefLabel
A highly selective and specific PET tracer for imaging of tau pathologies.
@ast
A highly selective and specific PET tracer for imaging of tau pathologies.
@en
A highly selective and specific PET tracer for imaging of tau pathologies.
@nl
P2093
P356
P1476
A highly selective and specific PET tracer for imaging of tau pathologies.
@en
P2093
A Katrin Szardenings
Anjana Sinha
Changhui Liu
Chunfang Xia
Daniel K Cashion
Dhanalakshmi Kasi
Fanrong Mu
P304
P356
10.3233/JAD-2012-120712
P577
2012-01-01T00:00:00Z